DCTH Declines After CHEMOSAT Receives Standard Review
Short Ideas - After much anticipation over the last few weeks, Delcath Systems (NASDAQ:DCTH) announced Monday that the New Drug Application for its CHEMOSAT hepatic chemosaturation system has … Continue Reading
Read now